Click here for slides on this topic


Metabolic syndrome

Medical conditions that, when taken together, increase the risk for type 2 diabetes and/or cardiovascular disease (CVD). Defining criteria from the American Heart Association and National Cholesterol Education Program include: waist circumference >40 inches in men and >35 inches in women; TG ≥150 mg/dL; HDL-C <40 mg/dL in men, <50 mg/dL in women; BP ≥130/85 mm Hg or treatment of previously diagnosed hypertension; and fasting plasma glucose (FPG) ≥100 mg/dL or previously diagnosed type 2 diabetes.
The following content matched the glossary term: Metabolic syndrome

AACE 2015 guidelines Diabetes Diagnosis

Top

Summary of recommendations for screening and diagnosing type 2 diabetes from the 2015 AACE guidelines. 

NDEI.org Expert Commentary on Type 2 Diabetes Prevention in SEQUEL from Vivian Fonseca

Top

NDEI Education Council Member Vivian A. Fonseca, MD, comments on type 2 diabetes prevention in a substudy of SEQUEL: “Weight loss alone may be an option to prevent type 2 diabetes”

NDEI.org Expert Commentary ACCORD BP Trial Henry Ginsberg

Top

Expert commentary from Henry Ginsberg, MD on post-hoc analysis of ACCORD BP trial examining the potential interaction between obesity and intensive blood pressure treatment on CVD outcomes.

Waist-to-Height Ratio and Cardiovascular Risk Factors in Elderly Individuals at High Cardiovascular Risk

Top

Guasch-Ferré M, Bulló M, Martínez-González MÁ, Corella D, Estruch R, Covas MI, Arós F, Wärnberg J, Fiol M, Lapetra J, Muñoz MÁ, Serra-Majem L, Pintó X, Babio N, Díaz-López A, Salas-Salvadó J. Waist-to-Height Ratio and Cardiovascular Risk Factors in Elderly Individuals at High Cardiovascular Risk. PLoS One. 2012;7(8):e43275. Several anthropometric measurements have been associated with cardiovascular disease, type-2 diabetes mellitus and other cardiovascular risk conditions, such as hypertension or metabolic syndrome.

American Diabetes Association 72nd Scientific Sessions Daily Coverage June 9, 2012

Top

Daily coverage of American Diabetes Association 72nd Scientific Sessions  June 9, 2012

Results from the EASIE, EUREXA, TODAY, and Diabetes Prevention Program (DPP) trials; new data on SGLT2 inhibitors for diabetes treatment, incretins for diabetes treatment, ATP-IV guideline update, and more.

 

American Diabetes Association 72nd Scientific Sessions Daily Coverage June 8, 2012

Top

Daily coverage of American Diabetes Association 72nd Scientific Sessions  June 8, 2012

Diabetes and hypoglycemia, clinical management of diabetes, obesity treatment, diabetes in long-term care, and more. 

Glycemic Control: How Low Should You Go?

Top

Glycemic Control: How Low Should You Go? NDEI Education Council Co-Chair Burton E. Sobel, MD, provides expert commentary on the debate over intensive versus somewhat less intensive glycemic control in the context of a recent study by Zhao et al assessing the impact of hypoglycemia associated with antihyperglycemic medications on vascular risk in type 2 diabetes

Clinical Insights in Diabetes Newsletter Archive

Top

Clinical Insights® in Diabetes Newsletter Archive

Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome

Top

Sakurai T, Iimuro S, Araki A, Umegaki H, Ohashi Y, Yokono K, Ito H. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus. Gerentology. 2010;56(2):141-149. OBJECTIVE: To determine the relationship among age-associated changes in obesity, insulin resistance, and clustering of MetS-type risk factors, in association with vascular complications, in Japanese elderly with type 2 diabetes.

Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men

Top

Stancáková A, Javorský M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes. 2009;58(5):1212-1221. We evaluated insulin sensitivity and insulin secretion across the entire range of fasting (FPG) and 2-h plasma glucose (PG), and we investigated the differences in insulin sensitivity and insulin release in different glucose tolerance categories.

1 2 3 4 5 6 7 8 9 10 Next 

Slide Library Results

Search Results for: Metabolic syndrome Slides Found: 35
Prevalence of the Insulin Resistance Syndrome (NCEP) in the US Population
Low-Carbohydrate Diet vs Low-Fat Diet
ARIC: Association Between MetS Components and CHD Risk
Waist Circumference, TG Levels Predict Future MetS in 18- to 19-Yr-Old Females
Prevalence of IFG, IGT, and Prediabetes by Cardiometabolic Risk Factors
Risk of CVD Mortality Risk rate Among Men with MetSyn and Diabetes, Alone and in Combination
Hazard Ratios of CVD Mortality Among Men With MetSyn and Diabetes, Alone and in Combination
JUPITER Analysis: Design
JUPITER Analysis: Baseline Characteristics 0 or ≥1 Major Diabetes Risk Factor*
JUPITER Analysis: Increased Diabetes Risk With ≥1 Risk Factor* at Baseline
JUPITER Analysis: Risk Reduction With Rosuvastatin ≥1 Major Diabetes Risk Factor*
JUPITER Analysis: Risk Reduction With Rosuvastatin No Major Diabetes Risk Factor*
JUPITER Analysis: Conclusions
JUPITER: Statin Therapy for Primary Prevention of Cardiovascular Disease—Participant Profile
JUPITER Results: Summary
HPS2-THRIVE: Niacin and Vascular Risk
AIM-HIGH: Niacin + Statin Therapy for Cardiovascular Risk Reduction
AIM-HIGH: Design
AIM-HIGH: Baseline Characteristics
AIM-HIGH: Lipid Values at Baseline and 2 Years
AIM-HIGH: Rate of the Primary Endpoint
AIM-HIGH: Rate of Secondary Endpoints
ESH/ESC Hypertension Guidelines: Hypertension Treatment for People With Metabolic Syndrome
SEQUEL Subanalysis: Percent Weight Loss from Baseline at Wk 108 Primary Endpoint
SEQUEL Subanalysis: Annualized Incidence of Type 2 Diabetes at Wk 108
SEQUEL Subanalysis: Reduction of Type 2 Diabetes Incidence Related to Greater Weight Loss
SEQUEL Subanalysis: Design
Canola Oil Glycemic Control CVD Type 2 Diabetes | NDEI
Efficacy of Phentermine + Topiramate for Weight Loss With BMI ≥35
ADA Type 1 Diabetes Guidelines Diagnosis Clues Slide | NDEI
Nut Intake Associated With Lower Metabolic Syndrome Risk ENDO2015 | NDEI
AACE 2015 Diabetes Guidelines Glucose Values Indicating Prediabetes PPT | NDEI
JUPITER Insulin Resistance Associated With Risk Factors | NDEI
JUPITER Incident Diabetes Associated With More Risk Factors Rosuvastatin | NDEI
NLA Cholesterol Guidelines Metabolic Syndrome Criteria | CCMD